Research has shown the safety of combining Sputnik V with other vaccines

by time news

A study in Argentina found no serious side effects when the first component of the Sputnik V coronavirus vaccine was combined with drugs from AstraZeneca and Sinopharm. This was announced by the provincial government of Buenos Aires.

“In the course of the conducted safety study of the Sputnik V vaccine combination with AstraZeneca and Sinopharm preparations, no serious side effects were revealed,” it was reported.

According to the Argentine Ministry of Health, 41.6% of the study participants did not have any complications after the second vaccination. At the same time, 50% reported pain at the injection site, and 8.4% reported fever and back pain. The average age of the study participants was 49 years. It is noted that there is no information on the effectiveness of the vaccine yet.

.

You may also like

Leave a Comment